GlassScriptPhysician profile
John R Ayres
NPI 1831165281
$584.08
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $102 · 2021: $39.51 · 2022: $46.12 · 2023: $14.59 · 2024: $14.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $29.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $29.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $236.17 | 2019-2021 | |
| Nevro Corp. | $63.27 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.09 | 2019-2020 | |
| Amgen INC. | $37.96 | 2019 | |
| Collegium Pharmaceutical, INC. | $36.00 | 2019 | |
| Painteq LLC | $29.40 | 2023-2024 | Painteq |
| Si-Bone, INC. | $29.36 | 2022 | |
| Biodelivery Sciences International, INC. | $27.80 | 2019-2020 | |
| Pfizer INC. | $18.39 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $17.16 | 2019 | |
| Nalu Medical, INC. | $16.76 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.60 | 2019 | |
| Zyla Life Sciences, INC. | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ayres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.